Ribo Life Science Sets 27 Aug 2026 Board Meeting to Approve 1H26 Results and Consider Interim Dividend

Bulletin Express

08/17

Ribo Life Science has scheduled a board meeting for Thursday, 27 August 2026. Directors will review and approve the unaudited results for the six months ended 30 June 2026, decide on the timing of their publication, and discuss a potential interim dividend.

The meeting agenda also includes any additional business matters that may arise.

As of the announcement date (17 August 2026), the Board comprises three executive directors—Dr. Liang Zicai (Chairman), Dr. Gan Liming and Dr. Zhang Hongyan—three non-executive directors—Dr. Qi Fei, Mr. Li Dongfang and Mr. Li Yuhui—and three independent non-executive directors—Dr. Yu Xuefeng, Mr. Ma Chaosong and Mr. Wang Ruiping.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1140772281"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1140772281\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1140772281?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 17:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140772281","market":"us","top_or_hot":-1,"title":"Ribo Life Science Sets 27 Aug 2026 Board Meeting to Approve 1H26 Results and Consider Interim Dividend","media":"Bulletin Express","content":"<p>Ribo Life Science has scheduled a board meeting for Thursday, 27 August 2026. Directors will review and approve the unaudited results for the six months ended 30 June 2026, decide on the timing of their publication, and discuss a potential interim dividend.</p>\n<p>The meeting agenda also includes any additional business matters that may arise.</p>\n<p>As of the announcement date (17 August 2026), the Board comprises three executive directors—Dr. Liang Zicai (Chairman), Dr. Gan Liming and Dr. Zhang Hongyan—three non-executive directors—Dr. Qi Fei, Mr. Li Dongfang and Mr. Li Yuhui—and three independent non-executive directors—Dr. Yu Xuefeng, Mr. Ma Chaosong and Mr. Wang Ruiping.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ribo Life Science Sets 27 Aug 2026 Board Meeting to Approve 1H26 Results and Consider Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRibo Life Science Sets 27 Aug 2026 Board Meeting to Approve 1H26 Results and Consider Interim Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-17 17:06</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Ribo Life Science has scheduled a board meeting for Thursday, 27 August 2026. Directors will review and approve the unaudited results for the six months ended 30 June 2026, decide on the timing of their publication, and discuss a potential interim dividend.</p>\n<p>The meeting agenda also includes any additional business matters that may arise.</p>\n<p>As of the announcement date (17 August 2026), the Board comprises three executive directors—Dr. Liang Zicai (Chairman), Dr. Gan Liming and Dr. Zhang Hongyan—three non-executive directors—Dr. Qi Fei, Mr. Li Dongfang and Mr. Li Yuhui—and three independent non-executive directors—Dr. Yu Xuefeng, Mr. Ma Chaosong and Mr. Wang Ruiping.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06938","symbol_name":"瑞博生物-B","start_time":0,"source_url":"","article_id":"1140772281","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140772281","pubTimestamp":1786957617,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Ribo Life Science has scheduled a board meeting for Thursday, 27 August 2026. Directors will review and approve the unaudited results for the six months ended 30 June 2026, decide on the timing of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06938":"瑞博生物-B"},"translate_title":"日博生命科学定于 2026 年 8 月 27 日召开董事会会议，批准 26 年上半年业绩并考虑中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06938":1},"content_text":"Ribo Life Science has scheduled a board meeting for Thursday, 27 August 2026. Directors will review and approve the unaudited results for the six months ended 30 June 2026, decide on the timing of their publication, and discuss a potential interim dividend.\nThe meeting agenda also includes any additional business matters that may arise.\nAs of the announcement date (17 August 2026), the Board comprises three executive directors—Dr. Liang Zicai (Chairman), Dr. Gan Liming and Dr. Zhang Hongyan—three non-executive directors—Dr. Qi Fei, Mr. Li Dongfang and Mr. Li Yuhui—and three independent non-executive directors—Dr. Yu Xuefeng, Mr. Ma Chaosong and Mr. Wang Ruiping.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}